Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Portugal

Coordination and Support Action · Running

NOVA_i4SF Nova Institute for a Sustainable Future

Coordinator
Universidade Nova De Lisboa, Portugal
Runs
1 January 2027 to 31 December 2032
Status
Running
EU funding
€15.0m
Total cost
€15.0m
Partners
3 organisations in 2 countries
Type
Coordination and Support Action
Grant agreement
101250540

What the project is doing

In the project's own words, from its summary on CORDIS.

The NOVA_i4SF will establish a Centre of Excellence (CoE) in Human and Environmental Health for a Sustainable Future at NOVA School of Science and Technology (NOVA), in strategic partnership with Leiden University (LU) and Leiden University Medical Center (LUMC). The CoE aims to transform the pharmaceutical industry by pioneering eco-friendly active pharmaceutical ingredients and sustainable processes, thereby significantly reducing environmental impact.

Pharmaceutical pollution is a serious threat to ecosystems and human health, accentuated by pharmaceutical industry emissions and residues. By leveraging advanced research in green solvents, molecular biology, integrative omics, and AI-based tools, with Leiden’s expertise, NOVA_i4SF will address challenges in sustainable (bio)pharmaceuticals. The CoE’s objectives include creating an autonomous research hub, ensuring long-term sustainability through robust funding, building a world-class team, delivering cutting-edge research, and offering specialized training.

The project also emphasizes transdisciplinary approaches, forging strong ties with industry, and securing alignment with EU missions. Through Sparkling Research Projects, the CoE will accelerate the discovery of sustainable therapies and pioneer environmentally conscious drug development. A governance structure with dedicated boards will guide NOVA_i4SF’s scientific agenda, with strategic investments fueling new facilities, advanced analytical equipment, and synergy with existing consortia.

Empowering NOVA's R&D facilities and Leiden’s global networks, the CoE will drive new research strands and foster industry collaborations, addressing the lack of a centralised hub for sustainable pharmaceutical processes in EU. NOVA_i4SF aspires to serve as a global leader in the design, production, and dissemination of greener, safer pharmaceutical solutions, driving innovation and competitive growth while benefiting society, the environment, and the EU Research Area.

Topics

Who is involved

OrganisationCityCountryRole
Universidade Nova De LisboaLisboaPortugalCoordinator
Academisch Ziekenhuis LeidenLeidenNetherlandsParticipant
Universiteit LeidenLeidenNetherlandsParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS